BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26792318)

  • 1. Appropriate indications for positron emission tomography/computed tomography, 2015.
    Vorster M; Doruyter A; Brink A; Mkhize S; Holness J; Malan N; Nyakale N; Warwick JM; Sathekge M;
    S Afr Med J; 2015 Oct; 106(1 Pt 2):105-22. PubMed ID: 26792318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate indications for positron emission tomography/computed tomography: College of Nuclear Physicians of the Colleges of Medicine of South Africa.
    Sathekge M; Warwick JM; Doruyter A; Vorster M
    S Afr Med J; 2015 Nov; 105(11):894-6. PubMed ID: 26632309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study.
    Cautela J; Alessandrini S; Cammilleri S; Giorgi R; Richet H; Casalta JP; Habib G; Raoult D; Mundler O; Deharo JC
    Europace; 2013 Feb; 15(2):252-7. PubMed ID: 23148119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, appropriateness, and consequences of recommendations for additional imaging tests in oncological PET/CT reports.
    Shinagare AB; Shyn PB; Sadow CA; Wasser EJ; Catalano P
    Clin Radiol; 2013 Feb; 68(2):155-61. PubMed ID: 22892243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
    Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience with 18f-fluoro-deoxy-glucose positron emission tomography/computed tomography in pediatric oncology patients.
    Odalović S; Sobić-Saranović D; Pavlović S; Grozdić I; Saranović D; Petrović M; Milovanović A; Petrasinović Z; Djurić-Stefanović A; Obradović V
    Acta Chir Iugosl; 2011; 58(4):67-73. PubMed ID: 22519195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma: A Review.
    Taghipour M; Sheikhbahaei S; Marashdeh W; Solnes L; Kiess A; Subramaniam RM
    JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):79-85. PubMed ID: 26583955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic 18F-FDG PET/CT: referring physicians' point of view.
    Karantanis D; Kalkanis D; Allen-Auerbach M; Bogsrud TV; Subramaniam RM; Danielson A; Lowe VJ; Czernin J
    J Nucl Med; 2012 Oct; 53(10):1499-505. PubMed ID: 22917886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positron emission tomography 2013 in Germany. Results of the query and current status].
    Kotzerke J; Oehme L; Grosse J; Hellwig D;
    Nuklearmedizin; 2015; 54(2):53-9. PubMed ID: 25650552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT: appropriate application in lymphoma.
    Wang X
    Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
    Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A
    Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET and PET/CT.
    Krause BJ; Schwarzenböck S; Souvatzoglou M
    Recent Results Cancer Res; 2013; 187():351-69. PubMed ID: 23179888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diagnosing prosthetic graft infections post cardiac and proximal thoracic aortic surgery.
    Guenther SP; Cyran CC; Rominger A; Saam T; Kazmierzcak PM; Bagaev E; Pichlmaier M; Hagl C; Khaladj N
    Interact Cardiovasc Thorac Surg; 2015 Oct; 21(4):450-8. PubMed ID: 26174118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT-directed biopsy: does it offer incremental benefit?
    Purandare NC; Kulkarni AV; Kulkarni SS; Roy D; Agrawal A; Shah S; Rangarajan V
    Nucl Med Commun; 2013 Mar; 34(3):203-10. PubMed ID: 23353885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.